{"id":"W4402091733","doi":"10.1002/ejhf.3383","title":"Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction","year":2024,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Health Care Foundation","funders":"National Institutes of Health; Daiichi-Sankyo; University of Glasgow; Moderna; Sarepta Therapeutics; Respicardia; Sanofi Pasteur; Sun Pharma; Regeneron Pharmaceuticals; Alnylam Pharmaceuticals; MyoKardia; Gilead Sciences; Cytokinetics; American Regent; Sanofi; Bayer; Intas Pharmaceuticals; AstraZeneca; Eli Lilly and Company; Celladon Corporation; Amgen","keywords":"Medicine; Ejection fraction; Hazard ratio; Heart failure; Internal medicine; Atrial fibrillation; Cardiology; Heart failure with preserved ejection fraction; Confidence interval; Myocardial infarction; Bisoprolol; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005865936,0.0006100045,0.001761464,0.0009716247,0.0002591323,0.001112975,0.0006126553,0.0006744421,0.0009257972],"category_scores_gemma":[0.00670233,0.0004017283,0.004119306,0.00122873,0.0003123957,0.0005489876,0.0007246755,0.000800862,0.0001070479],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002700687,"about_ca_system_score_gemma":0.0003925251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001538425,"about_ca_topic_score_gemma":0.00179685,"domain_scores_codex":[0.9955127,0.002727468,0.0006543556,0.0005813574,0.0003498977,0.0001742207],"domain_scores_gemma":[0.9929345,0.0029215,0.002635772,0.0007514364,0.0003685611,0.0003881963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02324982,0.0002187774,0.931837,0.0007821253,0.03659416,0.00009493515,0.00005436117,0.0003732259,0.0006322443,0.00006234876,0.0003199796,0.005780953],"study_design_scores_gemma":[0.003382996,0.002167094,0.9659173,0.0001696144,0.02548046,0.0002670342,0.00008697239,0.001156344,0.0003595552,0.0002700809,0.000714017,0.00002864262],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808758,0.0161896,0.0007241914,0.000156554,0.00008923729,0.00008157135,0.001399225,0.00001233583,0.0004714925],"genre_scores_gemma":[0.9973132,0.00112276,0.0003018436,0.0001041186,0.00009990607,0.00005482635,0.0009285303,0.000003126861,0.00007168888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005865936,"threshold_uncertainty_score":0.03102237,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0149775286070615,"score_gpt":0.2446841143481799,"score_spread":0.2297065857411184,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}